The Journal of Allergy and Clinical Immunology
Volume 120, Issue 3 , Pages 586-593 , September 2007

IFN-γ–induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations

  • Peter A.B. Wark, BMed, PhD

      Affiliations

    • Brooke Laboratories, University of Southampton, Southampton, United Kingdom
    • Department of Respiratory and Sleep Medicine, John Hunter Hospital, University of Newcastle, Newcastle, Australia
    • Corresponding Author InformationReprint requests: Peter A. B. Wark, BMed, PhD, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Locked Bag 1 HRMC, NSW 2310, Australia.
    • ,
  • Fabio Bucchieri, MD

      Affiliations

    • Department of Experimental Medicine, Human Anatomy Division, University of Palermo, Palermo, Italy
    • ,
  • Sebastian L. Johnston, MD, PhD

      Affiliations

    • Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom
    • ,
  • Peter G. Gibson, MBBS

      Affiliations

    • Department of Respiratory and Sleep Medicine, John Hunter Hospital, University of Newcastle, Newcastle, Australia
    • ,
  • Lynnsey Hamilton, BSci, PhD

      Affiliations

    • Brooke Laboratories, University of Southampton, Southampton, United Kingdom
    • ,
  • Joanna Mimica

      Affiliations

    • Department of Respiratory and Sleep Medicine, John Hunter Hospital, University of Newcastle, Newcastle, Australia
    • ,
  • Giovanni Zummo, MD

      Affiliations

    • Department of Experimental Medicine, Human Anatomy Division, University of Palermo, Palermo, Italy
    • ,
  • Stephen T. Holgate, FRCP

      Affiliations

    • Brooke Laboratories, University of Southampton, Southampton, United Kingdom
    • ,
  • John Attia, MD, PhD

      Affiliations

    • Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia
    • ,
  • Ammarin Thakkinstian, MD

      Affiliations

    • Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, Australia
    • Clinical Epidemiology Unit, Mahidol University, Bangkok, Thailand
    • ,
  • Donna E. Davies, PhD

      Affiliations

    • Brooke Laboratories, University of Southampton, Southampton, United Kingdom

Received 16 February 2007 ,Revised 18 April 2007 ,Accepted 19 April 2007.

References 

  1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of the role of viral infections in exacerbations of asthma in 9-11year old children. BMJ. 1995;310:1225–1228
  2. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982–986
  3. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med. 1996;154:654–660
  4. Lemanske J, Robert F, Jackson DJ, Gangnon RE, Evans MD, Li Z, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571–577
  5. Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child. 1998;79:12–17
  6. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003;362:1433–1438
  7. Wark PAB, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002;19:68–75
  8. Grunberg K, Sharon RF, Sont JK, In'T Veen JCCM, Van Schadwjik WAAM, De Klerk EPA, et al. Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med. 2001;164:1816–1822
  9. Chung KF, Barnes PJ. Cytokines in asthma. Thorax. 1999;54:825–857
  10. Jacoby D. Virus-Induced asthma attacks. JAMA. 2002;287:755–762
  11. National Heart, Lung, and Blood Institute . Global strategy for asthma management and prevention. Bethesda (MD): National Heart, Lung, and Blood Institute; 1995;p. 1-110
  12. Hurd SZ. Workshop summary and guidelines: investigative use of bronchoscopy. J Allergy Clin Immunol. 1991;88:808–814
  13. Bucchieri F, Lordon J, Richter A, Buchanan D, Djukanovic R, Holgate ST, et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol. 2001;27:179–185
  14. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-B-mediated transcription. J Biol Chem. 1999;274:9707–9720
  15. Johnston SL, Sanderson G, Pattemore PK, Smith S, Bardin PG, Bruce CB, et al. Use of polymerase chain reaction for the diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1992;31:111–117
  16. Grissell TV, Powell H, Shaffren DR, Boyle MJ, Hensley MJ, Jones PD, et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005;172:433–439
  17. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest. 1995;96:549–557
  18. Schroth MK, Grimm E, Frindt P, Galagan D, Konno S-I, Love R, et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol. 1999;20:1220–1228
  19. Terajima M, Yamaya M, Sekizawa K, Okinaga S, Suzuki T, Yamada N, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Phyiol Lung Cell Mol Physiol. 1997;273:L749–L759
  20. Fraenkel DJ, Bardin P, Sanderson G, Holgate ST, Johnston SL. Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1995;151:879–886
  21. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol. 1996;98:766–780
  22. Konno S, Grindle KA, Lee W-M, Schroth MK, Mosser AG, Brockman-Schneider RA, et al. Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26:594–601
  23. Stacey MA, Sun G, Vassalli G, Marini M, Bellini A, Mattoli S. The allergen Der p1 induces NF-κB activation through interference with IκBα function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun. 1997;236:522–526
  24. Spurrell JCL, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL 10) in vitro and in vivo upon rhinovirus infection. Am J Phyiol Lung Cell Mol Physiol. 2005;289:L85–L95
  25. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, et al. RF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 2002;17:251–263
  26. Wark PAB, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937–947
  27. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol. 1999;162:3840–3850
  28. Annunziato F, Cosmi L, Galli G, Beltrame C, Romagnani P, Manetti R, et al. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol. 1999;65:691–699
  29. Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA. Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:281–289
  30. Loetscher P, Pellegrino A, Gong J, Mattioli I, Loetscher M, Giuseppe Bardi MB, et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem. 2001;276:2986–2991
  31. Thomas MS, Kunkel SL, Lukacs N. Differential Role of IFN-γ-inducible protein 10 kDa in a cockroach antigen-induced model of allergic airway hyperreactivity: systemic versus local effects. J Immunol. 2002;169:7045–7053
  32. Nanki T, Lipsky PE. Lack of correlation between chemokine receptor and TH1/TH2 cytokine expression by individual memory T cells. Int Immunol. 2000;12:1659–1666
  33. Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, et al. CXCR3 expression and activation of eosinophils: role of IFN-γ-inducible protein-10 and monokine induced by IFN-γ. J Immunol. 2000;165:1548–1556
  34. Sedgwick JB, Menon I, Gern JE, Busse W. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J Allergy Clin Immunol. 2002;110:752–756
  35. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363:271–275
  36. Zhang Y, Simpson AA, Ledford RM, Bator CM, Chakravarty S, Skochko GA, et al. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J Virol. 2004;78:11061–11069
  37. Lagging M, Romero AI, Weston J, Norkans G, Dhillion AP, Zeuzam S, et al. IP-10 predicts viral response and therapeutic outcome in difficult to treat patients with HCV genotype 1 infection. Hepatology. 2006;44:1617–1625
  38. Heymann PW, Holliday TC, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalised for wheezing. J Allergy Clin Immunol. 2004;114:239–247
  39. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet. 1999;353:364–369
  40. Rodrigo GJ, Rodrigo C. Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment. Chest. 2000;118:1547–1552
  41. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699–1705
  42. Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, Hughes JM, et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med. 2005;171:1103–1108
  43. Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, Di Stefano A, et al. High serum levels of tumour necrosis factor-alpha; and interleukin-8 in severe asthma: markers of systemic inflammation?. Clin Exp Allergy. 2006;36:1373–1381

 Supported by the British Medical Association HC Roscoe fellowship and Asthma UK. Dr Wark was funded by the National Health and Medical Research Council of Australia on a Neil Hamilton Fairley traveling fellowship.

 Disclosure of potential conflict of interest: P. A. B. Wark has consultant arrangements with AstraZeneca, has a patent licensing arrangement from antivirus therapy for respiratory diseases, and receives grants/research support from Biota Pty, Ltd. S. L. Johnston has consultant arrangements with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, MedImmune, Merck, Pfizer, Sanofi-Aventis, Schering-Plough, and Synairgen; has patent licensing arrangements for transgenic animal models of HRV with human intercellular adhesion molecule 1 sequences, antivirus therapy for respiratory diseases, and the use of IFN-λ for the treatment and prevention of virally induced exacerbation in asthma and chronic pulmonary obstructive disease; and receives grants/research support from AstraZeneca, Centocor, GlaxoSmithKline, Pfizer, and Merck. S. T. Holgate has consultant arrangements with Synairgen, Novartis, Merck, Cambridge Antibody Technology, Almiral, and Rotta; owns stock in Synairgen; receives grant support from Novartis and UCB; and is on the speakers' bureau for Novartis and Merck. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01025-1

doi: 10.1016/j.jaci.2007.04.046

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 3 , Pages 586-593 , September 2007

Article Tools

* Image Usage & Resolution